United States bioinformatics market is anticipated
to register growth with an impressive CAGR in the forecast period, 2023-2027,
on the account of increasing biotechnological procedures and techniques. Also,
rising technical advancements like nucleic acid and protein sequencing, genetic
engineering, and storage of the then found data and its analysis further drives
the growth of the United States bioinformatics market in the upcoming five
years. Rising demands for the biotechnological procedures for advancing
medicine, finding the cure for diseases etc. also supports the growth of the
United States bioinformatics market in the next five years.
Application of the tools of computation
and analysis to collection and interpretation of the biological data is termed
as bioinformatics. A conjugation of multiple fields like medicine, computer
science, mathematics, physics, forms bioinformatics. Moreover, the storage of
the human genome project data and other similar genomic projects aids to the
growing requirements of bioinformatics. The storage of the genome mapping data
helps in analyzing underlying genomes and thus translated protein information
of any new species. Microorganisms like bacteria, virus, fungi have tendency to
mutate rapidly. The infectious diseases thus caused often leads to the urgency
for devising treatments and vaccines against the microbes. The recent pandemic is
one such example that actively utilized functions of bioinformatics in
formulating the genome mapping of the coronavirus and its strain along with the
vaccine and the pharmaceuticals.
Prevalence of Rare Diseases Promises
Market Growth
Rapid outbreaks of new diseases and
growing prevalence of infectious diseases with unidentified strains of
microorganisms, and their adversities drive the growth of the United States
bioinformatics market in the upcoming five years. The definition of rare
diseases in the country depends on the population it affects in a country or a
region for a prolonged period of time. In the United States, if a disease
affects less than 200,000 people it is categorized as a rare disease. In the
recent times, the rare diseases along with the infections have grown rapidly
and affected large population in the country.
Recent pandemic affected the worldwide
population. In United States, over 81 million cases have been recorded in the
country by March 2022 where 997,933 people died due to COVID-19. The United
States was one of the few countries that came up with the vaccination and
pharmaceuticals for the viral infection, and the use of bioinformatics for the
purpose was a boon. Therefore, the prevalent nature of such infectious diseases
would support the growth of the United States bioinformatics market in the next
five years.
Technological Advancement Guides Market
Growth
Growing advancement in the
biotechnological procedures and processes drives the market growth. Moreover,
the evolution of big data technology is also fueling the technical advancement
in the bioinformatics field. Using the technology for the analysis of the
protein structure, functions, and further predictive analysis is substantiating
the growth of the United States bioinformatics market in the future five years.
Moreover, developments in systems biology and genomic analysis of
pharmaceuticals have helped personalized medicine to transit from
disease-centered and reductionism-based medical practice to system-based,
integrative, and human-centered care.
Furthermore, increasing investment for
the research and advancement in the bioinformatic systems & services is
another major factor aiding the growth of the United States bioinformatics
market. In the year 2021, USD597.26 billion was spent over research and
development in the healthcare sector. A large section was involved in
pharmaceutical advancement and data storage regarding new protein translations,
thus substantiating market growth in the country.
Click here to download the sample
Market Segmentation
The United
States bioinformatics market is segmented by product & services, type,
application, end user, competitional landscape, and regional distribution. Based on product & services, the
market is further segmented into bioinformatics tools,
bioinformatics platforms, and bioinformatics services. By type, the market is
fragmented into genomics & proteomics, simulation studies & molecular
modelling, genetic engineering, and others. Based on application, the market is
bifurcated into metagenomics, drug discovery, precision medicine, and others.
By end user, the market is differentiated between institutional research and
industrial research. The
market analysis also studies the regional segmentation to devise regional
market segmentation, divided among South region, Mid-West region, North-East
region, and West region.
Company Profile
Illumina, Inc., Thermo Fischer
Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., 23AndMe,
DataTrack International, Inc., Biovia-Dassault Systemes, Waters Corporation, SOPHiA
GENETICS, among others is a
partial list of major market players of the companies responsible for the
growth of United States bioinformatics market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered | - Product & Services
- Type
- Application
- End User
|
|
Regional scope
|
South region, Mid-West region, North-East region, and West
region.
|
|
Key companies profiled
|
Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent
Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., 23AndMe, DataTrack
International, Inc., Biovia-Dassault Systemes, Waters Corporation, SOPHiA
GENETICS
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, United States bioinformatics market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
- United States Bioinformatics Market,
By Product & Services:
- Bioinformatics
Tools
- Bioinformatics
Platforms
- Bioinformatics
Services
- United States Bioinformatics Market,
By Type:
- Genomics
& Proteomics
- Simulation
Studies & Molecular Modelling
- Genetic
Engineering
- Others
- United States Bioinformatics Market,
By Application:
- Metagenomics
- Drug
Discovery
- Precision
Medicine
- Others
- United States Bioinformatics Market,
By End User:
- Institutional
Research
- Industrial
Research
- United States Bioinformatics Market,
By Region:
o South Region
o Mid-West Region
o North-East Region
o West Region
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in United States bioinformatics market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following customization
options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
United States Bioinformatics
Market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]